NasdaqGM - Delayed Quote USD

Tandem Diabetes Care, Inc. (TNDM)

Compare
43.50 -0.70 (-1.58%)
At close: August 30 at 4:00 PM EDT
43.50 0.00 (0.00%)
After hours: August 30 at 4:17 PM EDT
Loading Chart for TNDM
DELL
  • Previous Close 44.20
  • Open 44.78
  • Bid --
  • Ask --
  • Day's Range 42.85 - 45.95
  • 52 Week Range 13.82 - 53.69
  • Volume 1,006,827
  • Avg. Volume 1,601,773
  • Market Cap (intraday) 2.848B
  • Beta (5Y Monthly) 1.34
  • PE Ratio (TTM) --
  • EPS (TTM) -2.09
  • Earnings Date Oct 30, 2024 - Nov 4, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 54.18

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

www.tandemdiabetes.com

2,400

Full Time Employees

December 31

Fiscal Year Ends

Recent News: TNDM

View More

Performance Overview: TNDM

Trailing total returns as of 8/30/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

TNDM
47.06%
S&P 500
18.42%

1-Year Return

TNDM
58.35%
S&P 500
25.59%

3-Year Return

TNDM
60.57%
S&P 500
25.26%

5-Year Return

TNDM
40.65%
S&P 500
93.14%

Compare To: TNDM

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TNDM

View More

Valuation Measures

Annual
As of 8/30/2024
  • Market Cap

    2.85B

  • Enterprise Value

    2.87B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.56

  • Price/Book (mrq)

    12.18

  • Enterprise Value/Revenue

    3.61

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -17.15%

  • Return on Assets (ttm)

    -10.16%

  • Return on Equity (ttm)

    -48.48%

  • Revenue (ttm)

    796M

  • Net Income Avi to Common (ttm)

    -136.49M

  • Diluted EPS (ttm)

    -2.09

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    452.42M

  • Total Debt/Equity (mrq)

    204.00%

  • Levered Free Cash Flow (ttm)

    -35.61M

Research Analysis: TNDM

View More

Company Insights: TNDM

Research Reports: TNDM

View More

People Also Watch